Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
Status:
Completed
Trial end date:
2017-02-22
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the efficacy, safety, and tolerability of a once
daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle
Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an
Evaluator's Global Severity Score [EGSS] of 3 [moderate] or 4 [severe]).
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.